Market Tracker

08/24 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

24.29
Delayed Data
As of 3:59pm ET
 -1.33 / -5.19%
Today’s Change
23.59
Today|||52-Week Range
43.63
-43.22%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close25.62
Today’s open25.52
Day’s range24.19 - 25.92
Volume436,908
Average volume (3 months)526,918
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-56.98%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+4.43+13.71%
CEMPCempra Inc-1.66-7.26%
INSYINSYS Therapeutics I...-0.67-4.09%
DERMDermira Inc-2.04-6.02%
Data as of 4:01pm ET, 08/24/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.11
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts